Retinoic acid and arsenic trioxide sensitize acute promyelocytic leukemia cells to ER stress Academic Article uri icon

  • Overview
  • Research
  • Identity
  • Additional Document Info
  • View All


  • Retinoic acid (RA) in association with chemotherapy or with arsenic trioxide (ATO) results in high cure rates of acute promyelocytic leukemia (APL). We show that RA-induced differentiation of human leukemic cell lines and primary blasts dramatically increases their sensitivity to endoplasmic reticulum (ER) stress-inducing drugs at doses that are not toxic in the absence of RA. In addition, we demonstrate that the PERK pathway, triggered in response to ER stress, has a major protective role. Moreover, low amounts of pharmacologically induced ER stress are sufficient to strongly increase ATO toxicity. Indeed, in the presence of ER stress, ATO efficiently induced apoptosis in RA-sensitive and RA-resistant APL cell lines, at doses ineffective in the absence of ER stress. Our findings identify the ER stress-related pathways as potential targets in the search for novel therapeutic strategies in AML.


  • Masciarelli, S
  • Capuano, E
  • Ottone, T
  • Divona, M
  • De Panfilis, S
  • Banella, C
  • Noguera, NI
  • Picardi, A
  • Fontemaggi, G
  • Blandino, Giovanni
  • Lo-Coco, F
  • Fazi, F

publication date

  • February 2018